601127，涨停！成交额A股第一

Group 1: Market Performance - A number of leading stocks reached historical highs, including well-known industry leaders such as BYD, CITIC Bank, and Xinlitai, as well as niche market leaders like Hengxin Life, which saw a 20% limit-up increase [1] - BYD's stock rose by 4.22%, driving strength in the automotive supply chain, with seven out of the top ten stocks by trading volume belonging to the automotive sector [1] - The Shanghai Composite Index increased by 0.08%, the Shenzhen Component Index rose by 0.5%, and the ChiNext Index gained 0.48% [1] Group 2: Pharmaceutical Sector - The pharmaceutical sector showed strong performance, with significant gains in chemical pharmaceuticals, CRO, medical services, and innovative drugs [5] - Heng Rui Pharmaceutical's listing on the Hong Kong stock market saw a 30.87% increase, boosting sentiment in the pharmaceutical sector [8] - Multiple significant drugs received approval for market entry, including the innovative drug Anglazavir from Guangdong Zhongsheng Pharmaceutical, which led to a limit-up for the company [9]